Why a Planned Reorganization of the FDA Creates Major Challenges.
Publication
, Journal Article
Gottlieb, S; McClellan, MB
Published in: JAMA health forum
May 2025
Duke Scholars
Published In
JAMA health forum
DOI
EISSN
2689-0186
ISSN
2689-0186
Publication Date
May 2025
Volume
6
Issue
5
Start / End Page
e252326
Citation
APA
Chicago
ICMJE
MLA
NLM
Gottlieb, S., & McClellan, M. B. (2025). Why a Planned Reorganization of the FDA Creates Major Challenges. JAMA Health Forum, 6(5), e252326. https://doi.org/10.1001/jamahealthforum.2025.2326
Gottlieb, Scott, and Mark B. McClellan. “Why a Planned Reorganization of the FDA Creates Major Challenges.” JAMA Health Forum 6, no. 5 (May 2025): e252326. https://doi.org/10.1001/jamahealthforum.2025.2326.
Gottlieb S, McClellan MB. Why a Planned Reorganization of the FDA Creates Major Challenges. JAMA health forum. 2025 May;6(5):e252326.
Gottlieb, Scott, and Mark B. McClellan. “Why a Planned Reorganization of the FDA Creates Major Challenges.” JAMA Health Forum, vol. 6, no. 5, May 2025, p. e252326. Epmc, doi:10.1001/jamahealthforum.2025.2326.
Gottlieb S, McClellan MB. Why a Planned Reorganization of the FDA Creates Major Challenges. JAMA health forum. 2025 May;6(5):e252326.
Published In
JAMA health forum
DOI
EISSN
2689-0186
ISSN
2689-0186
Publication Date
May 2025
Volume
6
Issue
5
Start / End Page
e252326